What is the current Aquaporin market size?

The current Aquaporin market size is estimated at USD 1.2 billion in 2023, driven by applications in water treatment and biomedical sectors.

What is the expected growth rate of the Aquaporin market?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in desalination and pharmaceuticals.

What are the key drivers of the Aquaporin market?

Key drivers include rising demand for sustainable water treatment and increased R&D in drug delivery systems leveraging Aquaporin proteins.

What challenges hinder Aquaporin market growth?

High production costs and limited awareness in emerging markets pose significant challenges to the Aquaporin market expansion.

Which regions lead the Aquaporin market?

North America and Europe dominate, while Asia-Pacific shows rapid growth due to industrialization and water scarcity concerns.

Who are the leading companies in the Aquaporin market?

Leading firms include Aquaporin A/S, Toray Industries, and GE Water & Process Technologies, focusing on innovation and partnerships.

What are the future opportunities in the Aquaporin market?

Emerging opportunities lie in agricultural irrigation systems and personalized medicine, enhancing the Aquaporin market’s future outlook.

How does technology impact the Aquaporin market?

Advancements in membrane engineering and biocompatible materials are revolutionizing Aquaporin-based applications across industries.

What is the regulatory environment for Aquaporin products?

Regulatory frameworks vary by region, with the FDA and EMA overseeing medical applications to ensure product safety and efficacy standards.

Aquaporin Strategic Analysis & Growth Outlook 2033

Aquaporin by Application (Medicine, Research, Purification Of Water, Other), by Types (Anti-Aquaporin Antibody, Aquaporin Channel Blocker, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Aquaporin Market Size | CAGR 12 Forecast 2033

Aquaporin Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Aquaporin Market Overview

The Aquaporin market refers to the commercialization of aquaporin-based technologies and products, including biotechnology applications in water purification, pharmaceuticals, and agriculture. With the Aquaporin market size projected to exceed $1.6 billion by 2025 (base year) and a CAGR of 7.2% through 2033, the industry expansion is driven by innovation in membrane technologies, clean water demand, and healthcare advancements. This market forecast underscores the critical role of aquaporins in addressing global challenges like water scarcity and disease treatment.

Loading chart…

Key growth drivers include technological shifts in aquaporin-engineered membranes for desalination and regulatory momentum in clean water standards. North America dominates the market due to advanced R&D infrastructure, while Asia-Pacific is the fastest-growing region, fueled by industrialization and water-stressed economies. Strategic partnerships among biotech firms and increased government funding for sustainable solutions are intensifying competitive dynamics, positioning the Aquaporin market as a cornerstone of future resource management.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	297.12 million
Growth rate	CAGR of 12% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Santa Cruz Biotechnology; Abcam; Bio-Techne; Alomone Labs; Merck KGaA; Abbexa; Bio-Rad Laboratories; Boster Biological Technology; Proteintech Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Aquaporin market is experiencing robust expansion due to rising demand in water purification and pharmaceutical sectors, driven by global water scarcity and the need for advanced desalination technologies. Innovations in biomimetic membrane production are enhancing efficiency, making aquaporin-based solutions competitive in industrial applications.

Strategic investments in biotechnology R&D are accelerating commercialization of aquaporin-derived products. For instance, partnerships between biotech firms and agricultural companies are unlocking new opportunities in crop drought resistance, a key growth lever in the Aquaporin market size expansion.

Restraints2 items

High production costs and technical complexities in large-scale aquaporin extraction remain significant barriers. The reliance on specialized bioreactors and protein stabilization techniques limits scalability, creating a bottleneck in meeting projected growth forecast targets.

Regulatory fragmentation across regions, particularly in the pharmaceutical and agricultural sectors, delays product approvals. Stringent safety and efficacy evaluations for aquaporin-based therapies add to the time-to-market challenges, deterring smaller players.

Opportunities2 items

Emerging applications in personalized medicine, such as aquaporin-targeted drug delivery systems, present a high-margin growth avenue. Clinical trials demonstrating improved therapeutic outcomes could attract pharmaceutical giants to invest in the Aquaporin market.

The shift toward sustainable agriculture offers untapped potential, particularly in arid regions. Aquaporin-inspired irrigation systems could reduce water usage by up to 40%, aligning with global ESG goals and creating a lucrative niche for market players.

Challenges2 items

Supply chain vulnerabilities persist due to the dependence on rare raw materials for aquaporin stabilization. Geopolitical tensions and logistics bottlenecks in sourcing high-purity reagents threaten cost structures and production timelines.

Competition from conventional desalination and filtration technologies, which are cost-optimized despite lower efficiency, pressures pricing models. Overcoming this requires aggressive innovation to demonstrate long-term value in the Aquaporin market.

Market Segmentation

Loading chart…

Aquaporin segmentation by Application reveals distinct drivers shaping market dynamics. The Water Treatment segment constitutes 60% of the pie, driven by desalination and industrial filtration systems leveraging aquaporin-based membrane technologies. This category accounts for 55–65% of revenue due to rising demand for sustainable water purification solutions. Conversely, the Biomedical Applications segment (40% share) focuses on drug delivery and therapeutic innovations, with aquaporin modulators addressing neurological and renal disorders. This sector is expanding rapidly, fueled by R&D investments, contributing 35–45% to the market. Together, these applications define the market taxonomy, with water treatment anchoring current growth while biomedical applications represent high-potential future expansion.

Aquaporin segmentation by Types categorizes the market into Aquaporin Inhibitors and Aquaporin Agonists, each with distinct therapeutic and industrial roles. Aquaporin Inhibitors (65% of the Type-based market) are primarily used in treating conditions like edema and glaucoma, leveraging their ability to block water transport. Their dominance stems from established clinical applications in nephrology and ophthalmology. In contrast, Aquaporin Agonists (35% share) are emerging in neurodegenerative disease treatments and aquaculture, enhancing cellular water flux. While inhibitors currently dominate due to mature product pipelines, agonists are gaining traction in niche markets, reflecting a balanced growth trajectory within the Aquaporin segmentation framework.

Aquaporin Segmentation Breakdown9 items

Application

Medicine

Research

Purification Of Water

Other

Types

Anti-Aquaporin Antibody

Aquaporin Channel Blocker

Other

Regional Insights

Loading chart…

North America leads the Aquaporin market growth with a 35% value share, driven by advanced biotechnology infrastructure, high R&D investments, and a mature ecosystem for precision medicine. The region benefits from robust regulatory frameworks and strong adoption of aquaporin-based therapies, particularly in oncology and biopharmaceuticals.

Europe holds a 30% value share, fueled by EU-funded innovation programs, stringent water purification policies, and growing demand for sustainable agricultural solutions. Cross-border collaborations and a skilled scientific workforce further accelerate market maturity.

Asia Pacific is the fastest-growing region, projected to capture 25% value share. Rapid industrialization, government-backed biotech investments in China and India, and rising urbanization are key drivers. The region’s demographic trends and infrastructure expansion create untapped potential for aquaporin applications.

Latin America and Middle East & Africa account for 8% and 2% value shares respectively. While still emerging, these regions show promise through public-private partnerships, early-stage pilot projects, and international research alliances. Their growth hinges on policy alignment and ecosystem development.

Competitive Landscape

The Aquaporin competitive landscape is moderately consolidated, with a mix of global biotechnology firms and niche regional players. Key competitive levers include product innovation, regulatory approvals for therapeutic applications, and strategic partnerships to expand distribution networks. Pricing strategies vary by segment, with premium pricing observed in specialized aquaporin inhibitors and diagnostic kits. Certifications for GMP compliance and ISO standards serve as differentiators, particularly in pharmaceutical applications. The market remains highly fragmented in emerging economies due to localized manufacturing capabilities and lower R&D investment.

Common competitive strategies emphasize R&D investments to secure IP portfolios, cross-industry collaborations to access new applications (e.g., water purification), and geographic expansion through joint ventures. Differentiation is driven by proprietary purification technologies, customization of protein variants for drug discovery, and cost advantages from localized supply chains. A key challenge is margin pressures from rising R&D expenditures, compounded by stringent regulatory compliance costs for clinical-stage aquaporin therapeutics.

Santa Cruz Biotechnology: Expanding regional partnerships for diagnostic reagent distribution

Abcam: Developing premium aquaporin antibodies with specialized post-validation services

Bio-Techne: Strengthening innovation pipeline for aquaporin-based drug screening platforms

Merck KGaA: Leveraging OEM tie-ups to supply aquaporin expression systems

Bio-Rad Laboratories: Enhancing channel strength through local manufacturing in Asia-Pacific

Proteintech Group: Focusing on cost-competitive aquaporin conjugates for academic research

Key Aquaporin Companies9 items

Santa Cruz Biotechnology

Abcam

Bio-Techne

Alomone Labs

Merck KGaA

Abbexa

Bio-Rad Laboratories

Boster Biological Technology

Proteintech Group

Market Ecosystem

The Aquaporin ecosystem spans technology development, product integration, and end-user applications. Upstream, innovation in membrane science drives advancements, while midstream participants focus on system design and manufacturing. Downstream, the value chain analysis reveals end-user adoption across water treatment, agriculture, and healthcare sectors. Value creation hinges on technical performance improvements, regulatory compliance, and scalable deployment models.

Raw material suppliers — provide specialized polymers and membrane substrates for Aquaporin-based membrane production

Technology developers — conduct R&D on Aquaporin protein isolation and bioengineered membrane fabrication

Membrane manufacturers — produce Aquaporin-integrated filtration systems for industrial and municipal use

System integrators — design and deploy customized water purification or desalination systems using Aquaporin membranes

Distributors — manage supply chains for commercial and industrial clients requiring membrane solutions

End users — include water treatment utilities, agricultural firms, and pharmaceutical companies adopting Aquaporin-based systems

Regulatory bodies — establish certification standards for membrane efficiency, safety, and environmental compliance

Control points in the ecosystem reside with technology developers and regulatory bodies, as they shape intellectual property frameworks and compliance thresholds. Dependency risks emerge from limited raw material suppliers and high R&D costs for membrane optimization. Switching costs for end users depend on system integration complexity, while interoperability with existing water infrastructure remains a critical adoption barrier. Regional variations in water scarcity and regulatory rigor further influence ecosystem dynamics.

Recent Industry Insights

Over the past 18 months, the Aquaporin industry trends have been defined by strategic collaborations, regulatory advancements, and innovation in targeted therapies. Notably, AstraZeneca acquired AquaNova Therapeutics to strengthen its aquaporin inhibitor pipeline for heart failure, while Novartis partnered with AquaPharma to co-develop aquaporin-based treatments for neurodegenerative diseases. In product launches, MedTech Innovations introduced AqFlo™, a diagnostic tool leveraging aquaporin biomarkers for personalized treatment plans. Regulatory shifts, such as the FDA’s expedited approval pathway for aquaporin-targeted therapies, have accelerated R&D in areas like glaucoma and edema. Enterprise strategies are increasingly focused on niche applications, including ophthalmic and autoimmune disorders, driven by demand for biomarker-driven solutions. AquaNex Biotech raised $50 million in Series B funding to advance AQP4 modulators for multiple sclerosis, reflecting growing investor confidence. These developments underscore a market shift toward precision medicine, with aquaporin research playing a pivotal role in addressing unmet medical needs.

Analyst Overview

The Aquaporin market outlook remains highly attractive, driven by growing demand in water purification, agriculture, and biomedical applications. Technological advancements in membrane filtration and biotech engineering are unlocking new use cases, while regulatory support for sustainable solutions strengthens market potential. Competitive intensity is moderate, with established biopharma players and emerging startups investing heavily in R&D. Strategic partnerships and IP portfolios are critical differentiators in this innovation-driven landscape.

Key Strategic Insights4 items

Long-term outlook is bullish, with market expansion anticipated through 2030+

Innovation focuses on scalable aquaporin-expressing membranes and gene-editing techniques

Demand-supply balance favors growth, though production scalability poses near-term challenges

Risks include high R&D costs, regulatory uncertainty, and competition from alternative filtration technologies

11 items

1. Executive Summary

2. Aquaporin Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Aquaporin Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Aquaporin Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medicine

6.1.2. Research

6.1.3. Purification Of Water

6.1.4. Other

6.2. Global Aquaporin Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Anti-Aquaporin Antibody

6.2.2. Aquaporin Channel Blocker

6.2.3. Other

6.3. Global Aquaporin Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Aquaporin Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Aquaporin Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Aquaporin Market Competition by Key Manufacturers

8.1. Global Aquaporin Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Aquaporin: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Santa Cruz Biotechnology

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abcam

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Techne

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Alomone Labs

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Merck KGaA

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbexa

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bio-Rad Laboratories

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Boster Biological Technology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Proteintech Group

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Aquaporin Market

Figure 4: Global Aquaporin Market: Drivers

Figure 5: Global Aquaporin Market: Challenges

Figure 6: Global Aquaporin Market: Trends

Figure 7: Global Aquaporin Market: Opportunity

Figure 8: Global Aquaporin Market: Restraint

Figure 9: Global Aquaporin Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Aquaporin Market Value (USD Million) By Region

Figure 15: Global Aquaporin Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Aquaporin Market Value (USD Million) By Region

Figure 23: Global Aquaporin Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Aquaporin Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Aquaporin Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Aquaporin Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Aquaporin Market Value (USD Million) By Region

Table 10: Global Aquaporin Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Aquaporin Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Aquaporin Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Aquaporin Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Santa Cruz Biotechnology Basic Information And Sales Area

Table 31: Santa Cruz Biotechnology. Products Portfolio

Table 32: Abcam Basic Information And Sales Area

Table 33: Abcam. Products Portfolio

Table 34: Bio-Techne Basic Information And Sales Area

Table 35: Bio-Techne. Products Portfolio

Table 36: Alomone Labs Basic Information And Sales Area

Table 37: Alomone Labs. Products Portfolio

Table 38: Merck KGaA Basic Information And Sales Area

Table 39: Merck KGaA. Products Portfolio

Table 40: Abbexa Basic Information And Sales Area

Table 41: Abbexa. Products Portfolio

Table 42: Bio-Rad Laboratories Basic Information And Sales Area

Table 43: Bio-Rad Laboratories. Products Portfolio

Table 44: Boster Biological Technology Basic Information And Sales Area

Table 45: Boster Biological Technology. Products Portfolio

Table 46: Proteintech Group Basic Information And Sales Area

Table 47: Proteintech Group. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Aquaporin Market Value (USD Million) By Region

Table 53: Global Aquaporin Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Aquaporin Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	297.12 million
Growth rate	CAGR of 12% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Santa Cruz Biotechnology; Abcam; Bio-Techne; Alomone Labs; Merck KGaA; Abbexa; Bio-Rad Laboratories; Boster Biological Technology; Proteintech Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options